Diseases requiring painless bronchoscopy
Conditions
Interventions
Remazolam benzosulfonate Group (Group A):None
Propofol group (Group B):None
Remazolam benzosulfonate combined with Propofol group (Group C):None
Sponsors
Chongqing Public health medical treatment Center
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Patients selected for painless fiberoptic treatment in our hospital; 2. age > 18 years old, male or female; 3. The patient voluntarily signs a written informed consent; 4. American Society of Anesthesiologists Grade I-III.
Exclusion criteria
Exclusion criteria: 1. Patients who are known to be allergic to any of the drug components intended for use or who have contraindications to any of the medications; 2. Patients with long-term use of benzodiazepines; 3. Patients with severe renal dysfunction (requiring kidney replacement therapy); 4. Patients who are participating in any interventional clinical trial; 5. Individuals with hearing, intellectual, communication, or cognitive impairments 6.Patients who, for any reason, are unable to cooperate with the study or are deemed by the investigator to be unsuitable for participation in this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulse Oxygen Saturation;Feasibility of diagnosis and treatment procedures (vocal cord movement, coughing, body movement);Non-invasive blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain at the injection site;Patient's intention to review; | — |
Countries
China
Contacts
Public ContactRongdanTan
Chongqing Public health medical treatment Center
Outcome results
None listed